KatieB Posted August 22, 2018 Share Posted August 22, 2018 Quote Learn more about a clinical trial available for patients with non-small cell lung cancer harboring a RET alteration. Now enrolling, the Phase 1 ARROW clinical trial is testing an experimental medicine called BLU-667. The ARROW trial is open at multiple clinical sites in the United States, Europe and Asia. A travel support program is also available to qualified patients and caregivers to reimburse eligible local and long-distance travel and lodging. More information about the trial, including eligibility criteria and a list of active trial sites, is available at www.arrowtrial.com or www.clinicaltrials.gov (Identifier: NCT03037385). You can also contact the clinical trial sponsor, Blueprint Medicines, at (617)-714-6707 or firstname.lastname@example.org to be connected to a clinical trial site near you. Tom Galli 1 Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.